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ABSTRACT
Nuclear factor (erythroid-derived 2) -like 2 (Nrf2) is a transcription factor that plays an important role in the
cellular protection against free radical damage and reduce the incidence of radical derived degenerative diseases
such as cancer. Nrf2 is referred to as the "master regulator" of the antioxidant response due to the fact that it
modulates the expression of several genes including phase-2 and antioxidant enzymes playing a crucial role in
detoxification of electrophiles and reactive oxygen species (ROS), including glutathione-S-transferase (GST),
gamma-glutamyl  cysteine  ligase (γ-GCL), glutathione-S-reductase  (GSR), NAD(P)H:quinoneoxidoreductase-1
(NQO1), heme oxygenase-1 (HO-1), etc. Following dissociation from it obligatory partner Kelch like ECH-
associated protein 1 (Keap1), Nrf2 translocates to the nucleus and transactivates the antioxidant response element
(ARE) in the promoter region of several antioxidant genes. In this review, we discuss the role of the Nrf2 system,
with particular focus on Nrf2-controlled target genes.
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INTRODUCTION
Oxidative  and  electrophilic  stresses  provoke
physiological responses that induce the expression of
severalcytoprotective genes.
1 The transcription factor
Nrf2  was  identified  as  the  main  regulator  of  the
cytoprotective genes encoding phase 2 detoxification
and  antioxidant  enzymes.
2 Nrf2 originates  from
studies  of  β-globin  gene  expression  with  the
description  of  locus  control  region  as  possessing
substantial  regulatory  activities,  and relates to
transcription  factor  activating  protein-1(AP-1).
3
During the last few years,the role of Nrf2 has been
increasingly studied to show that Nrf2 activation can
protect  against  various  human  diseases  such  as
cancer. Using dietary or synthetic compounds to rise
Nrf2-mediated cellular defence responses, Nrf2 has
been progressively studied  in  diseases  prevention.
4
Numerous Nrf2 activators have been recognized and
their  efficacy  in  cancer  prevention  has  been
established both in animal and human experiments.
5,6
Nrf2  functions  to  promptly  alter  the  sensitivity  of
cells  to oxidative  and  electrophilic  compounds  by
stimulating  the  transcriptional  activation  of  various
cytoprotective and detoxification genes, including the
antioxidants ferritin
7, glutathione-S-reductase (GSR),
gamma-glutamyl  cysteine  ligase  (γ-GCL)
8,
NAD(P)H:quinoneoxidoreductase-1 (NQO1), and
heme  oxygenase-1  (HO-1).
9 In  homeostatic  status,
Nrf2 is constantly ubiquitinated through its inhibitory
partner Keap1. In response to electrophiles or ROS
stress,  cytosolic  Nrf2  liberates  itself  from
sequestration  or  negative  regulation  of  Keap1,
thereby releasing Nrf2 from proteasomal degradation
and translocates into the nucleus. Once in the nucleus,
Nrf2forms  a  heterodimer  complex  with various
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transcriptional  regulatory  proteins  such  as  small
Maf(sMaf) protein. This protein complex then binds
to  the  ARE,  which  is  located  in  the  upstream
promoter regions, leading to the induction of diverse
target cytoprotective genes.
10
THE NRF2:INRF2 (OR KEAP1) SYSTEM
The transcription factor Nrf2 is the master of redox
homeostasis because it regulates basal and inducible
expression of several antioxidants and cytoprotective
genes, providing protection against several diseases,
such  as  renal,  pulmonary,  cardiovascular,
neurodegenerative  diseases  and  cancer.
11 Nrf2  is  a
member  of  the cap  ‘n’  collar  (CNC)  family  basic
region-leucine  zipper  transcription  factor  that  also
includes  NF-E2,  Nrf1,  Nrf3,  Bach1,  and  Bach2.
12
Nrf2 protein has six NRF2-ECH homology domains
designated  as  Neh1-Neh6  respectively.
13 These
proteins serve as heterodimeric transcription factors
by dimerizing with other bZIP proteins such as the
sMaf.
14 As  shown  in  fig.  1,  the  first  conserved
domain, Neh1, is located in the half C-terminal of the
molecule,constitutes the basic DNA binding domain
and the leucine zipper for dimerization with other b-
Zip proteins.
15 Neh2  consists of  the  amino-terminal
region of the Nrf2 and serve as a negative regulator of
Nrf2.
16Neh3, in turn,located at the C-terminal end of
the protein and required for transcriptional activation
of  Nrf2.
12 Both  Neh4  and  Neh5  are  considered  as
transactivation  domains,  act  cooperatively  to  bind
another  transcriptional  co-activator,  the cAMP
response  element-binding  protein  (CREB)-binding
protein  (CBP), in  orderto  organize  the  start  of
transcription.
17 Neh6  is  a  redox-insensitive  degron
which is essential for negative regulation of Nrf2.
16
Fig 1: Nrf2 and Keap1 domains.
Upper panel: in Nrf2, Neh1 is the basic DNA binding
domain and the leucine zipper for dimerization. Neh2
is the Keap1 binding domain. Neh3 is required for
transcriptional  activation  of  the  protein.  Neh4  and
Neh5  domains  are important for  binding  to  ARE.
Neh6 is required for the negative control of Nrf2.
Lower  panel:  in  Keap1,  BTB  domain serves as  a
substrate  adaptor  protein  for  a  Cul3-dependent
ubiquitin ligase complex. IVR domain is a domain of
intervention  which  is  distinguished  for  its  high
number  of  cysteine  residues.  DGR  domain  is
associated  with  actin  filaments,  giving  stability  to
Keap1 (Adapted from Yoichiro et al).
18
It has been demonstrated that Nrf2 through its Neh2
domain interacts with Keap1 protein, also known as
inhibitor  of  Nrf2  (INrf2),  and  negatively  controls
Nrf2  function.
13 Keap1,  as  shown  in  fig.1, is
composed  of five  major  domains:  an  N-terminal
region (NTR), broad complex, tramtrack, and bric-a-
brac  domain  (BTB),  a  cysteine-rich  intervening
region (IVR), the double glycine repeat region (DGR)
or  Kelch  domain,  and  a  C  terminal  Kelch  region
(CTR). Keap1 forms  a homodimer  and each  dimer
binds  one  molecule  of  Nrf2    by  its  two  Kelch
domains, with one high affinity binding site (ETGF
motif)  and  one  weak  affinity  binding  site  (DLG
motif). Both motifs are located in Neh2 domain of
Nrf2.
19 The  ETGF  motif  has  a  higher  affinity  for
Keap1 than the DLG motif, and this is the so-called
‘‘hinge-and-latch’’ model.
20 Keap1 contains several
reactive  cysteine residues  that  serve  as  sensors  of
intracellular  redox  state,  among which  C273  and
C288,  connected  to  IVR,  are  critical  for  the
dissociation  of  Nrf2  from  Keap1 under  basal
conditions  and  their modulation by  inducers  may
diminish the rate of ubiquitination and degradation of
Nrf2. Cysteine residues C151, in the BTB domain, is
essential  for  repression  of  Nrf2  ubiquitination  by
electrophiles  or  oxidants.
21 Oxidative  or  covalent
modification  of  thiols  in some  of  these  cysteine
residues cause Nrf2 to  be released from keap1
sequestration with consequent  translocation  to  the
nucleus.
22 Once in the nucleus, Nrf2 heterodimerizes
with  the  sMaf  protein  in  the  upstream  promoter
regions of the ARE, leading to the induction of genes
encoding  antioxidant  and phase  2 detoxifying
enzyme.
15,23 These cytoprotective enzymes are crucial
for cell defence by improving the removal of ROS
and,  thus,  plays  a  protective  role  against  oxidative
stress.
24 Furthermore,  Nrf2  is  a  key  transcription
factor  involved  in  cytoprotection  against430
Atia et al., Int J Med Res Health Sci. 2014;3(2):428-435
inflammation  due  to its  ability  to  antagonize  the
transcription factor nuclear factor-kB (NF-kB), which
coordinates the expression of inflammatory genes.
25
Additionally, studies have suggested BTB and CNC
homology-1  (Bach1)  as  another control  mechanism
for Nrf2 activation. Bach1 is known to bind to the
Nrf2  site  as  a  heterodimer  with sMaf.
26 Upon
induction, Bach1 is substituted by Nrf2, leading to
activation and suggesting competition between Bach1
and Nrf2 for the same DNA binding site in various
cellular conditions.
27
NRF2 TARGET GENES
NRF2,  as  mentioned,  is  a  transcription  factor  that
controls  the  expression  of  phase  2  detoxification
genes. It heterodimerizes with members of the Maf
family of transcription factors and binds to the ARE
in the promoter regions of various phase 2 genes. The
impacts and functions of  some  of  the  main  Nrf2-
target genes will be discussed below. However, it is
not  easy  to  distinguish  which  particular  genes
activated by  Nrf2  are  most  significant  for  its
cytoprotectiverole;nevertheless it  is  clear that  the
coordinated induction of those genes has a dramatic
effect on cellular homeostasis.
Glutamate-cysteine ligase (GCL). GCL, also known
as  γ-glutamylcysteinesynthetase,  is  an  enzyme
composed  of  two  subunits:  a  modifier  subunit
(GCLM)  and  a  catalytic  subunit  (GCLC),  both  of
which  contain  ARE  sequences  in  their
promoters.
4,5GCLcatalyzes  the  first  step  in
glutathione  synthesis  (GSH),  the  most  significant
non-protein  thiol  in  the  cell.  GSH  maintains
intracellular  redox  balance  and  plays  an  important
role in detoxifying of xenobiotics, electrophiles and
protection  of  the  cell  from  reactive  molecules  and
oxidative insults. GSH can also detoxify chemicals
through  enzymatic  conjugation  by  glutathione-S-
transferases.
28,29Since GCL is a master determinant of
the  total  capacity  of  GSH  synthesis,  regulation  of
GCL  subunits  has  been  subjected  to  extensive
research.
30 Studies have identified  that  GCL  has
different levels  of  regulation, at  the  kinetic,  post
translational  and  transcriptional  levels, which
ultimately  affect either  the  catalytic  or  modifier
subunits  or  both.
31 The  regulation  of  GCL  at  the
transcriptional  level  provides morepersistent  effect
and  thus  is essential for  the  maintenance  of  GSH
homeostasis in  response  tooxidative  stress.
32The
Nrf2/ARE signalling is one of the major regulatory
pathways. Both of GCLC and GCLM contain AREs
in  their promoters.
33 Further,  manytranscription
factors have been reported to bind ARE, such as Nrf2
family members(Nrf1/2/3), sMaf (maf G/K/F), AP-1,
and Fos family members (c-Fos, FosB, Fra1, Fra2).
34
Among  them,  ARE-dependent  GCLC  gene
expression  is highly dependent  upon  Nrf2.
35In
addition,  researchers have identified  that  levels  of
GCLC and GCLM are decreased in Nrf2 knockout
mice, this leads to lack in GSH synthesis which is
lethal during embryogenesis.
36
Glutathione-S-transferases (GST). GSTs are multi-
gene family of phase II detoxification enzymes that
catalyse the conjugation of several endogenous and
exogenous  electrophilic  compounds  with  GSH.
37
GSTs  are  largely  distributed  in  nature,  being
presented  in  all  eukaryotes  and  in  various
prokaryotes.
38 In  mammals,  GSTs  are  divided  into
numerous cytosolic,  mitochondrial  and  microsomal
GST isoenzymes, also known as MAPEG (membrane
associated  proteins  in  eicosanoid  and  glutathione)
proteins,  according  to their  homologies  and
properties.
39 The cytosolic enzymes are encoded by
five related gene families (known as; alpha, mu, pi,
sigma, and theta GST), while the membrane-bound
enzymes and microsomal GST are encoded by single
genes and both have originated separately from the
soluble  GST.
37 It  has  been  suggested  that  phase  II
conjugation  enzymes,  particularly  GSTs,are Nrf2
target  genes  with  an  extremely  transactivational
ARE-like  motifs  demonstrated on  the  gene
promoter.
24 Studies have revealed that Nrf2 knockout
mice  exhibited  reduced  constitutive  and  inducible
expressions  of  many  GST  isoforms in  livers.
40
Moreover,  induction  of  hepatic  and  intestinal  GST
isoforms  by Butylatedhydroxytoluene  (BHA) and
ethoxyquin is also reduced in the absence of Nrf2.
41
NAD(P)H quinoneoxidoreductase 1 (NQO1). NQO1
is a cytosolic homodimericflavoprotein that is widely
expressed  in many tissues,  and  its  expression  is
regulated  by the  ARE both  in  basal  and  during
oxidative  stress  conditions.
42 NQO1catalyzes  two
electron-reduction and detoxification of a wide range
of  substrates,  most  prominentlyquinones  and  its
derivatives, protecting cells from reactive  forms  of
oxygen, oxidative stress, and neoplasia.
43 However,
in many cases, the reduction of quinones by NQO1
leads to the formation cytotoxic hydroquinones which431
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play  a  key  role in targeting  NQO1-rich  cancer
cells.
44NQO1  is  expressed  predominantly  in  all  the
tissues, and  its level  of  expression  differs among
human tissues. NQO1 is expressed at relatively high
levels in several tumor tissues including lung, liver,
colon, breast  and  pancreatic  tissues,  and  its
expression induced in  response  to  a  variety  of
xenobiotics,  antioxidants,  oxidants, and  heavy
metals.
45 Mutations and deletions in the NQO1 gene
promoter aided in recognizing the  core  ARE
sequence.
32 ARE is basically needed for  expression
and  coordinated  induction  of  NQO1  and  other
detoxifying  enzyme  genes.  Nrf2  bind  ARE  and
regulate  expression  and  induction  of NQO1  gene.
Meanwhile, Nrf2 knockout exhibited reduction in the
constitutive  expression  of  NQO1  and  impairs  its
induction.
42In addition, treatment with BHA, known
Nrf2 inducer, increases hepatic and intestinal NQO1
levels  in  wild-type,  but  not in Nrf2  knockout
mice.
45All of these data confirm a role for Nrf2 in the
expression of NQO1 in various tissues.
Superoxide  dismutases (SODs). SODsare  the  first
and  most  significant  line  of  antioxidant  enzyme
defence  systems  against several  ROS,particularly
superoxide  anion  radicals. SOD is an extremely
efficient enzyme, catalyses the dismutation  of  two
superoxide radicals to form hydrogen peroxide and
oxygen. Product of this gene is suggested to defend
the lungs and other tissues from oxidative stress.
46 In
mammalians, three  distinct  isoforms  of  SOD  have
been  identified;cytoplasmic  (SOD1),  mitochondrial
(SOD2),  and  extracellular  (SOD3).
47 SOD1  is  a
soluble  cytoplasmic  protein  that  binds  zinc  and
copper  ions, and  works  as  a  homodimer.  SOD2, a
protein found  in mitochondria in  a  homotetramer
form, binds the superoxide byproducts of oxidative
phosphorylation  and converts them  to  hydrogen
peroxide  and  diatomic  oxygen.  SOD3, in  turn,  is
secreted  into  the  extracellular  space  and  forms  a
glycosylated  homotetramer  that  is linked to  the
extracellular  matrix  and  cell  surfaces  via  an
interaction  with heparin sulfate  proteoglycan  and
collagen.
46Researchers have identified that SOD3 but
not SOD2 and SOD1 is induced by antioxidants, and
is  regulated  through  Nrf2. Therefore,  SOD3
suggested  as an  important  gene  in  defence  against
oxidant  stress  and  in  the  prevention  of  estrogen-
mediated breast cancer.
48
Epoxide  hydrolases  (EHs).EHs are  multifunctional
enzymes that are essential for both the activation and
inactivation  of  reactive  species.  EHs  catalyse  the
hydrolysis  of  epoxides,  which  formed  by the
cytochrome P450-dependent monooxygenase (CYP)
superfamily, to a diol (known as dihydrodiols) by the
addition  of  water.
49 Two  mammalian  enzymes,
microsomal  (mEHor  EPHX1)  and soluble  epoxide
hydrolase (sEHor EPHX2), have been characterized
to play diverse roles in xenobiotic metabolism. mEH
is expressed in two  types.  Type-I mEHis  typically
located  in  the  hepatic  endoplasmic  reticulum  to
oppose epoxides  of  polycyclic  aromatics  and  make
them  into  diols.  Type-II  mEH  is positioned in  the
hepatocyte plasma membrane, where it controls the
absorption of  bile  acids  in  the  liver  in association
with  a  taurocholate  binding  protein. Meanwhile,
Soluble  epoxide  hydrolasealso  forms  diols  from
different endogenous and exogenous epoxides, and is
expressed  in  most  tissues such  as; liver,  lung  and
kidney. sEH regulates  many  pathways  linked  to
endogenous systems including; fatty  acid  and
leukotriene epoxide metabolism, and is involved in
blood  pressure  regulation  and  inflammatory
responses.
50 There are some evidence indicated that
EHs are regulated by the Nrf2 system. The mRNA
expression  of  mEH  has shown  to  be  decreased  in
various tissues of Nrf2 knockout mice. In addition,
treatmentof Nrf2 knockdown mice with prototypical
Nrf2 inducers, oltipraz, have not been found to induce
mEH  in  compare  to  the  wild  type.  These  results
highlights a role for Nrf2-mediated control.
51,52
Heme oxygenase-1 (HO-1). HO-1 is the extremely
inducible  rate-controlling  enzyme  of  heme
catabolism.
53 It catalyzes the rate-limiting step in the
degradation of heme into biliverdin, carbon monoxide
(CO),  and  free  iron.
54HO-1  has antioxidant,
cytoprotective,  anti-inflammatory,  and immune-
modulatory activities. These activities are suggested
to  be due to  its  ability  to reducehigh levels  of
potentially toxic heme within cells and to alter heme
to  less  reactive  iron which  can  be  stored  in  the
nontoxic form of ferritin.
55HO-1 plays a crucial role
in the maintenance of cellular redox homeostasis and
subsequentlyhinders transformation of normal cells to
malignant  cells by abolishing ROS-mediated
carcinogenesis.
56 However, increased levels of HO-1
and Nrf2 have been demonstrated in several types of
human malignancies. Studies have reported that Nrf2432
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regulates the induction of HO-1 in response to diverse
forms  of  cellular  stress,  including oxidative,
hemodynamic,  and  endoplasmic  reticulum  stress.
Additionally,  Nrf2-knockout animals have  been
found  to  express HO-1 at  low  levels, further
implicating Nrf2 in the induction of HO-1.
57
Multidrug  resistance-associated  proteins  (MRPs):
MRPs are ATP-dependent efflux transporters known
to  transport  a  variety  of  compounds,  particularly
glutathione, glucuronide, and sulfate conjugates, out
of cells. Four MRP transporters (MRP2, 3, 4, and 6)
of  the  eight  MRPs are  expressed  to  a  significant
extent in liver.
58 MRP2 is the only MRP localized to
the canalicular membrane and involves in excretion
of  chemicals  into  bile.  While,  MRP3,  MRP4  and
MRP6 are localized to the basolateral membrane and
serve as an efflux pump transporting chemicals from
hepatocytes into blood.
59 MRPs play major roles in
hepatic removal of metabolites, and modification of
MRPs expression  in  liver  can  convert  drug
disposition.
60 MRPs  have  been  demonstrated  to  be
induced by various Nrf2 activators, including BHA,
oltipraz,  and ethoxyquin.
61 Moreover,  other
transcription  factors,  such  as  NF-κB,  have  been
implicated  in  MRPs regulation,  suggesting that
another regulatory mechanisms might control MRPs
induction.
62
Beside  the  mentioned  genes  that  are  regulated  by
Nrf2, there are many other genes regulated by this
process that we cannot possibly include them in this
review.  But, what has shown in this section is the
most  known  genes  that  regulated  by  this
signallingmechanism, addressingtheir  implication
with  Nrf2  in  cytoprotection  against  ROS-mediated
carcinogenesis.
SUMMARY
Transcription  factor  Nrf2  regulates  basal  and
inducible expression of phase II detoxification genes
that  protect  animal  cells  against  toxic  effects  of
electrophiles and ROS. Under normal physiological
conditions, Nrf2 is sequestered in the cytoplasm by
Keap1,  a  multi-domain, cysteinerich protein  that is
bound to the actin cytoskeleton. Keap1 acts both as a
repressor of the Nrf2 transactivation and as a sensor
of phase 2 inducers. Electrophiles and oxidative stress
loose  the  interaction  between  Nrf2  and  the  Keap1
protein, allowing Nrf2 to translocate to the nucleus,
where it  forms  a  heterodimer  bound  with  its
obligatory  partner  sMaf  protein,  and  eventually
activates  ARE-dependent  gene  expression. These
genes are essential for detoxification of xenobiotics
and endogenous reactive intermediates.
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